Align Alanine--glyoxylate aminotransferase 2 homolog 2, mitochondrial; Beta-alanine-pyruvate aminotransferase 2; EC 2.6.1.44 (characterized)
to candidate AZOBR_RS19630 AZOBR_RS19630 4-aminobutyrate aminotransferase
Query= SwissProt::Q94AL9 (477 letters) >FitnessBrowser__azobra:AZOBR_RS19630 Length = 428 Score = 208 bits (530), Expect = 3e-58 Identities = 137/396 (34%), Positives = 208/396 (52%), Gaps = 13/396 (3%) Query: 91 LFDESGRRYLDAFAGIAVVNCGHCHPDVVEPVINQIKRLQHPTVLYLNH-AIADFSEALA 149 L+D G R++D GIAV+N GH HP ++E V Q+ R H + + + +E L Sbjct: 34 LWDVEGNRFIDFAGGIAVLNTGHRHPKIIEAVKAQLDRFTHTCAMVTPYESFVTLAERLN 93 Query: 150 SKLPGDL--KVVFFTNSGTEANELALMMAKLYTGCQDIVAVRNGYHGNAAATMGATGQSM 207 + +PG K FFT +G EA E A+ +A+ +TG ++A +HG M TG+ + Sbjct: 94 ALVPGSTPKKTAFFT-TGAEAVENAVKIARAHTGRPGVIAFSGAFHGRTLLAMALTGKVV 152 Query: 208 -WK--FNVVQNSVHHALNPDPYRGVFGSDGEKYAKDLQDLIQYGTTG-HIAGFICEAIQG 263 +K F V+HA P+ YRGV D K L+ L + +A I E +QG Sbjct: 153 PYKVGFGPFPAEVYHAPFPNAYRGVSVQDS---LKALEQLFKSDVDATRVAAIIVEPVQG 209 Query: 264 VGGIVELAPGYLSAAYDTVKKAGGLFIADEVQSGFARTGNFWGFEAHNVVPDIVTMAKGI 323 GG P +L A + G L I DE+Q+GFARTG + E V PD++TMAK + Sbjct: 210 EGGFNIAPPEFLQALRKICDENGILLIIDEIQTGFARTGKMFAIEHSGVEPDLMTMAKSL 269 Query: 324 GNGFPLGAVVTTPEIAGVLTRRSYFNTFGGNSVSTTAGLAVLNVIEKEKLQENAAMVGSY 383 GFPL AV EI T+ G+ ++TTA LAVL+VIE+EKL + + +G Sbjct: 270 AGGFPLSAVTGKAEIMDAPIPGGIGGTYAGSPLATTAALAVLDVIEEEKLIQRSNDLGER 329 Query: 384 LKEKLTQLKEKH--EIIGDVRGRGLMLGVELVSDRKLKTPATAETLHIMDQMKELGVLIG 441 + + + +++ +IGDVR G M+ +ELV DR K PA T ++ + E G+++ Sbjct: 330 IAGRFRTMAQRNTLSVIGDVRNLGGMIAMELVKDRGTKEPAAELTKALVAKAAEKGLVLL 389 Query: 442 KGGYFGNVFRITPPLCFTKDDADFLVEAMDYSMSKM 477 G +GNV RI PL + D ++ ++ S+ ++ Sbjct: 390 SCGTYGNVIRILVPLTASDALVDEGLDIIERSLEEL 425 Lambda K H 0.320 0.136 0.403 Gapped Lambda K H 0.267 0.0410 0.140 Matrix: BLOSUM62 Gap Penalties: Existence: 11, Extension: 1 Number of Sequences: 1 Number of Hits to DB: 475 Number of extensions: 22 Number of successful extensions: 5 Number of sequences better than 1.0e-02: 1 Number of HSP's gapped: 1 Number of HSP's successfully gapped: 1 Length of query: 477 Length of database: 428 Length adjustment: 33 Effective length of query: 444 Effective length of database: 395 Effective search space: 175380 Effective search space used: 175380 Neighboring words threshold: 11 Window for multiple hits: 40 X1: 16 ( 7.4 bits) X2: 38 (14.6 bits) X3: 64 (24.7 bits) S1: 41 (21.8 bits) S2: 51 (24.3 bits)
This GapMind analysis is from Aug 03 2021. The underlying query database was built on Aug 03 2021.
Each pathway is defined by a set of rules based on individual steps or genes. Candidates for each step are identified by using ublast (a fast alternative to protein BLAST) against a database of manually-curated proteins (most of which are experimentally characterized) or by using HMMer with enzyme models (usually from TIGRFam). Ublast hits may be split across two different proteins.
A candidate for a step is "high confidence" if either:
Otherwise, a candidate is "medium confidence" if either:
Other blast hits with at least 50% coverage are "low confidence."
Steps with no high- or medium-confidence candidates may be considered "gaps." For the typical bacterium that can make all 20 amino acids, there are 1-2 gaps in amino acid biosynthesis pathways. For diverse bacteria and archaea that can utilize a carbon source, there is a complete high-confidence catabolic pathway (including a transporter) just 38% of the time, and there is a complete medium-confidence pathway 63% of the time. Gaps may be due to:
GapMind relies on the predicted proteins in the genome and does not search the six-frame translation. In most cases, you can search the six-frame translation by clicking on links to Curated BLAST for each step definition (in the per-step page).
For more information, see the paper from 2019 on GapMind for amino acid biosynthesis, the paper from 2022 on GapMind for carbon sources, or view the source code, or see changes to Amino acid biosynthesis since the publication.
If you notice any errors or omissions in the step descriptions, or any questionable results, please let us know
by Morgan Price, Arkin group, Lawrence Berkeley National Laboratory